Cargando…

Hdac6 Knock-Out Increases Tubulin Acetylation but Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease

Huntington's disease (HD) is a progressive neurodegenerative disorder for which there is no effective disease modifying treatment. Following-on from studies in HD animal models, histone deacetylase (HDAC) inhibition has emerged as an attractive therapeutic option. In parallel, several reports h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bobrowska, Anna, Paganetti, Paolo, Matthias, Patrick, Bates, Gillian P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108987/ https://www.ncbi.nlm.nih.gov/pubmed/21677773 http://dx.doi.org/10.1371/journal.pone.0020696

Ejemplares similares

Genetic Knock-Down of Hdac3 Does Not Modify Disease-Related Phenotypes in a Mouse Model of Huntington's Disease
por: Moumné, Lara, et al.
Publicado: (2012)

Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease
por: Benn, Caroline L., et al.
Publicado: (2009)

SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo
por: Bobrowska, Anna, et al.
Publicado: (2012)

Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington’s Disease Phenotypes In Vivo
por: Bobrowska, Anna, et al.
Publicado: (2021)

Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease
por: Sathasivam, Kirupa, et al.
Publicado: (2010)

Caspase-6 does not contribute to the proteolysis of mutant huntingtin in the HdhQ150 knock-in mouse model of Huntington’s disease
por: Landles, Christian, et al.
Publicado: (2012)

EGF-induced sodium influx regulates EGFR trafficking through HDAC6 and tubulin acetylation
por: Lee, Seung Joon, et al.
Publicado: (2015)

CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin
por: Wickström, Sara A, et al.
Publicado: (2010)

Loss of Deacetylation Enzymes Hdac6 and Sirt2 Promotes Acetylation of Cytoplasmic Tubulin, but Suppresses Axonemal Acetylation in Zebrafish Cilia
por: Łysyganicz, Paweł K., et al.
Publicado: (2021)

Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington’s disease knock-in mice is blocked by Mlh1 knock-out
por: Loupe, Jacob M, et al.
Publicado: (2020)

RASSF1A Suppresses Cell Migration through Inactivation of HDAC6 and Increase of Acetylated α-Tubulin
por: Jung, Hae-Yun, et al.
Publicado: (2013)

Silencing Srsf6 does not modulate incomplete splicing of the huntingtin gene in Huntington’s disease models
por: Mason, Michael A., et al.
Publicado: (2020)

SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease
por: Mielcarek, Michal, et al.
Publicado: (2011)

The PDE1/5 Inhibitor SCH-51866 Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington’s Disease
por: Beaumont, Vahri, et al.
Publicado: (2014)

The Ubiquitin-Proteasome Reporter GFPu Does Not Accumulate in Neurons of the R6/2 Transgenic Mouse Model of Huntington's Disease
por: Bett, John S., et al.
Publicado: (2009)

MiR‐22‐3p inhibits fibrotic cataract through inactivation of HDAC6 and increase of α‐tubulin acetylation
por: Wang, Xiaoran, et al.
Publicado: (2020)

RASSF1A Regulates Spindle Organization by Modulating Tubulin Acetylation via SIRT2 and HDAC6 in Mouse Oocytes
por: Jeon, Hyuk-Joon, et al.
Publicado: (2020)

Why are the phenotypes of TRAF6 knock-in and TRAF6 knock-out mice so different?
por: Petrova, Tsvetana, et al.
Publicado: (2022)

Genetic deletion of S6k1 does not rescue the phenotypic deficits observed in the R6/2 mouse model of Huntington’s disease
por: Irvine, Elaine E., et al.
Publicado: (2019)

LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington’s Disease
por: Chopra, Vanita, et al.
Publicado: (2016)

Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6
por: Vanaja, G. R., et al.
Publicado: (2018)

Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly
por: Ran, Jie, et al.
Publicado: (2015)

The paxillin-plectin-EPLIN complex promotes apical elimination of RasV12-transformed cells by modulating HDAC6-regulated tubulin acetylation
por: Kasai, Nobuhiro, et al.
Publicado: (2018)

Dysferlin Interacts with Histone Deacetylase 6 and Increases alpha-Tubulin Acetylation
por: Di Fulvio, Sabrina, et al.
Publicado: (2011)

A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of huntington’s disease
por: Li, Endan, et al.
Publicado: (2023)

Phenotype onset in Huntington’s disease knock‐in mice is correlated with the incomplete splicing of the mutant huntingtin gene
por: Franich, Nicholas R., et al.
Publicado: (2019)

Formation of Polyglutamine Inclusions in a Wide Range of Non-CNS Tissues in the HdhQ150 Knock-In Mouse Model of Huntington's Disease
por: Moffitt, Hilary, et al.
Publicado: (2009)

Retraction: Dysferlin Interacts with Histone Deacetylase 6 and Increases alpha-Tubulin Acetylation
Publicado: (2018)

Transglutaminase 6 Is Colocalized and Interacts with Mutant Huntingtin in Huntington Disease Rodent Animal Models
por: Schulze-Krebs, Anja, et al.
Publicado: (2021)

The Huntington's Disease-Related Cardiomyopathy Prevents a Hypertrophic Response in the R6/2 Mouse Model
por: Mielcarek, Michal, et al.
Publicado: (2014)

Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of α-tubulin acetylation and FGF-21 up-regulation
por: Wang, Zhifei, et al.
Publicado: (2016)

Inducible knock-out of BCL6 in lymphoma cells results in tumor stasis
por: Schlager, Stefanie, et al.
Publicado: (2020)

HDAC6 in Diseases of Cognition and of Neurons
por: LoPresti, Patrizia
Publicado: (2020)

Histone Deacetylase 6 (HDAC6) Is an Essential Modifier of Glucocorticoid-Induced Hepatic Gluconeogenesis
por: Winkler, Robin, et al.
Publicado: (2012)

HDAC11: A novel inflammatory biomarker in Huntington’s disease
por: Kumar, Vishal, et al.
Publicado: (2022)

HDAC11 inhibition disrupts porcine oocyte meiosis via regulating α-tubulin acetylation and histone modifications
por: Huang, Rong, et al.
Publicado: (2021)

New HDAC6-mediated deacetylation sites of tubulin in the mouse brain identified by quantitative mass spectrometry
por: Liu, Ningning, et al.
Publicado: (2015)

HDAC6‐mediated α‐tubulin deacetylation suppresses autophagy and enhances motility of podocytes in diabetic nephropathy
por: Liang, Tiantian, et al.
Publicado: (2020)

Protein Acetylation and the Physiological Role of HDACs
por: Matthias, Patrick, et al.
Publicado: (2011)

Knock out
por: Carrillo, Darío, 1972-
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c32kacuel7vqsjuofr28lv4gqq